Today's most-trusted drug references - together in one easy-to-use, fully integrated database that dramatically speeds diagnosing and prescribing.
Over 9,000 pages of today's most-used medical references can now be accessed on your PC screen at the touch of a button!
It's easy to use! Just enter the first few letters of a drug name, and the data is on your screen. The information appears word-for-word from PDR, including chemical structures, illustrations, and full-color pill images.

The PDR Electronic Library contains the full text of the 2007 hysicians' Desk Reference, PDR for Nonprescription Drugs and Dietary Supplements, and PDR for Ophthalmic Medicines, as well as PDR Drug Interactions and Side Effects.

Quickly look up prescribing information six different ways: by brand name, generic name, manufacturer, therapeutic category, indication or side effect. Plus, Drug Interactions and Side Effects module (included) alerts you to potential problems in even the most complex regimen.

Available for Windows only. Equipment required: IBM PC compatible computer, MS Windows 95 or higher, 8 MB RAM, VGA Color Monitor, Double Speed CD-ROM drive, 10MB available on hard drive.

The Individual Version is for personal consumer use only. It does not include updates or optional modules. It's license does not allow institutional/business use.

The Authoritative Source of FDA-Approved Information on Prescription Drugs.

Physicians have turned to PDR® for the latest word on prescription drugs for 60years! Today, PDR is considered the standard prescription drug reference and can be found in virtually every physician's office, hospital and pharmacy in the United States. In fact, nine out of ten doctors consider PDR their most important reference source. The 60th edition is more than 3,000 pages—our most comprehensive edition ever! Our new format allows dramatically improved readability and easier access to the information you need now.

Among the new drugs featured in this edition are: Clarinex (desloratadine), a new long-acting H1-receptor antagonist indicated for the treatment of chronic idiopathic urticaria, and for the relief of seasonal and perennial allergic rhinitis symptoms; Xigris (drotrecogin alfa, activated), a new recombinant form of human Activated Protein C indicated for the reduction of mortality in adults with severe sepsis associated with acute organ dysfunction who have a high risk of death; Frova (frovatriptan succinate), the new selective 5-HT1 agonist indicated for the acute treatment of migraine attacks; Tracleer (bosentan), the first of a new drug class, an endothelin receptor antagonist, used to treat pulmonary arterial hypertension in patients with WHO Class III or IV symptoms, to improve exercise ability and decrease the rate of clinical worsening; Angiomax (bivalirudin), a reversible direct thrombin inhibitor indicated with aspirin for use as an anticoagulant in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty (PTCA); Ortho Evra (norelgestromin/ethinyl estradiol), the first transdermal contraceptive patch for the prevention of pregnancy; Advicor (niacin extended-release/lovastatin), a new combination lipid-altering agent used for the treatment of primary hypercholesterolemia and mixed dyslipidemia when single agents are inadequate; Nuvaring (etonogestrel/ethinyl estradiol), the first contraceptive vaginal ring for the prevention of pregnancy; Focalin (dexmethylphenidate HCl), a new CNS stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD); Kineret (anakinra), a new human interleukin-1 receptor antagonist approved to reduce the signs and symptoms of moderately to severely active rheumatoid arthritis after failure of one or more DMARDs; Bextra (valdecoxib), a new nonsteroidal anti-inflammatory COX-2 inhibitor indicated for the relief of the signs and symptoms of osteoarthritis and adult rheumatoid arthritis, and for the treatment of primary dysmenorrhea.

You'll find the most complete data on over 4,000 drugs by brand and generic name (both in the same convenient index), manufacturer and product categories. Your 2004 PDR provides usage information and warnings, drug interactions, plus more than 2,000 full-size, full-color photos cross referenced to the drug.

You'll also find:

• Phonetic spelling for each listing
• A key to controlled substances
• Adverse reactions
• Contraindications
• Pediatric Uses
• Clinical pharmacology
• FDA use-in-pregnancy ratings
• Dosages
• And all other FDA-required information
• For absolutely accurate information, you need the 2007 PDR!